Synthesis of 17-epi-calcitriol from a common androstane derivative, involving the ring B photochemical opening and the intermediate triene ozonolysis

Journal of Organic Chemistry

Volumn 70, Issue 21, 2005, Pages 8513-8521

  Kurek Tyrlik, Alicja ^a   Michalak, Karol ^a   Wicha, Jerzy ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; CHROMATOGRAPHIC ANALYSIS; DERIVATIVES; ESTERS; FISSION PRODUCTS; HORMONES; OXIDATION; OZONE; PHOTOLYSIS; REDUCTION; SYNTHESIS (CHEMICAL);

17-EPI-CALCITRIOL; ANDROSTANE; EPIMER; OZONOLYSIS;

ALCOHOLS;

17 ALPHA CHOLEST 5 EN 3BETA,25 DIOL; 17 EPI CALCITRIOL; 25 HYDROXYCHOLESTEROL; 3BETA,25 DIHYDROXY 17ALPHA CHOLEST 5 ENE 3 ACETATE; ANDROSTANE DERIVATIVE; CALCITRIOL DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CHOLESTEROL DERIVATIVE; CYCLOPROPANE DERIVATIVE; ESTER; KETONE; PALLADIUM; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ALKYLATION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CHEMICAL STRUCTURE; OXIDATION; OZONOLYSIS; PHOTOCHEMISTRY; PHOTOLYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

ANDROSTANES; CALCITRIOL; CYCLIZATION; FATTY ACIDS, OMEGA-3; MOLECULAR STRUCTURE; OZONE; PHOTOCHEMISTRY; STEREOISOMERISM;

EID: 26844515525     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo051357u     Document Type: Article

References (69)

1. Bouillon, R.; Okamura, W. H.; Norman, A. W. Endoc. Rev. 1995, 16, 200-257.
2. (a) Beckman, M. J.; DeLuca, H. F. In Progress in Medicinal Chemistry; Ellis, G. P., Luscombe, D. K., Oxford, A. W., Eds.; Elsevier: Amsterdam, 1998; Vol. 35, pp 1-56.
3. (b) Markus, R.; Feldman, D.; Kelsey, J. In Osteoporosis; Feldman, D., Malloy, P. J., Gross, C., Eds.; Academic Press: San Diago, 1996.
4. (a) Nordin, B. E. C.; Morris, H. A. J. Cell. Biochem. 1992, 49, 19-25.
5. (b) Kerkhof, P. C. M. v. d. Br. J. Dermatol. 1995, 132, 675-682.
6. (c) Tsoukas, C. D.; Provvedini, D. M.; Manolagas, S. C. Science 1984, 224, 1438-1440.
7. (a) Vegesna, V.; O'Kelly, J.; Said, J.; Uskoković, M.; Binderup, L.; Koeffle, H. P. Anticancer Res. 2003, 23, 283-289.
8. (b) Hansen, C. M.; Binderup, L.; Hamberg, K. J.; Carlberg, C. Front. Biosci. 2001, 6, D820-D848.
9. Maehr, H.; Uskokoviæ, M. R. Eur. J. Org. Chem. 2004, 1703-1713.
10. Recent works include: (a) Shi, B. F.; Wu, H.; Yu, B.; Wu, J. R. Angew. Chem., Int. Ed. 2004, 43, 4324-4327.
11. (b) Shimizu, H.; Shimizu, K.; Uchiyama, Y.; Sugita, A.; Mikami, T.; Yamauchi, T.; Kato, M.; Morikawa, K. Tetrahedron Lett. 2004, 45, 7837-7841.
12. (c) Posner, G. H.; Jeon, H. B.; Sarjeant, A.; Riccio, E. S.; Doppalapudi, R. S.; Kapetanovic, I. M.; Saha, U.; Dolan, P.; Kensler, T. W. Steroids 2004, 69, 757-762.
13. (d) Demin, S.; Van Haver, D.; Vandewalle, M.; De Clercq, P. J.; Bouillon, R.; Verstuyf, A. Bioorg. Med. Chem. Lett. 2004, 14, 3885-3888.
14. (e) Moman, E.; Nicoletti, D.; Mourino, A. J. Org. Chem. 2004, 69, 4615-4625.
15. For a recent review, see: Posner, G. H.; Kahraman, M. Eur. J. Org. Chem. 2003, 3889-3895.
16. Binderup, L.; Latini, S.; Binderup, E.; Bertting, C.; Calverley, M.; Hansen, K. Biochem. Pharmacol. 1991, 42, 1569-1575.
17. (a) Kurek-Tyrlik, A.; Makaev, F. Z.; Wicha, J.; Calverley, M. J. Liebigs Ann./Recueil 1997, 1997-2001.
18. (b) Kurek-Tyrlik, A.; Makaev, F. Z.; Wicha, J.; Zhabinskii, V.; Calverley, M. J. In Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone; Norman, A. W., Bouillon, R., Thomasset, M., Eds.; University of California,: Riverside (Calif.), 1997; p 30.
19. Zhou, X. M.; Zhu, G. D.; Van Haver, D.; Vandewalle, M.; De Clercq, P. J.; Verstuyf, A.; Bouillon, R. J. Med. Chem. 1999, 42, 3539-3556.
20. (a) Przezdziecka, A.; Achmatowicz, B.; Marczak, S.; Steinmeyer, A.; Wicha, J.; Zuegel, U. In Vitamin D Endocrine System. Proceedings of the 11th Workshop on Vitamin D; Norman, A. W., Bouillon, R., Thomasset, M., Eds.; University of California,: Riverside, CA, 2000; pp 81-84.
21. (b) Marczak, S.; Przezdziecka, A.; Wicha, J.; Steinmeyer, A.; Zuegel, U. Bioorg. Med. Chem. Lett. 2001, 11, 63-66.
22. (c) Achmatowicz, B.; Przezdziecka, A.; Wicha, J. Pol. J. Chem. 2005, 79, 413-428.
23. For total synthetic approach to steroid building block with an α-oriented carbon substituent at C-17, see: Stork, G.; Atwal, K. S. Tetrahedron Lett. 1983, 24, 3819-3822.
24. Windaus, A.; Lettre, H.; Schenck, F. Liebigs Ann. Chem. 1935, 520, 98-106.
25. For a review see: Zhu, G.-D.; Okamura, W. H. Chem. Rev. 1995, 95, 1877-1952.
26. (a) Paaren, H. E.; DeLuca, H. F.; Schnoes, H. K. J. Org. Chem. 1980, 45, 3253.
27. (b) Vanmaele, L.; Clercq, P. J. D.; Vandewalle, M. Tetrahedron 1885, 41, 141-144.
28. (c) Reischl, W.; Kalchhauser, H. Tetrahedron Lett. 1992, 33, 2451-2454.
29. Andrews, D. R.; Barton, D. H. R.; House, R. H.; Pechet, M. M. J. Org. Chem. 1986, 51, 4819-4828.
30. Velluz, L.; Amiard, G.; Petit, A. Bull. Soc. Chim. Fr. 1949, 16, 501-507.
31. (a) Lythgoe, B.; Moran, T. A.; Nambudiry, M. E. N.; Ruston, S.; Tideswell, J.; Wright, P. W. Tetrahedron Lett. 1975, 44, 3863-3866.
32. (b) Baggiolini, E. G.; Iacobelli, J. A.; Hennessy, B. M.; Batcho, A. D.; Sereno, J. F.; Uskokovi'c, M. R. J. Org. Chem. 1986, 51, 3098-3108.
33. For a review, see: Kabat, M. M.; Radinov, R. Curr. Opin. Drug Discovery Dev. 2001, 4, 808-832.
34. A preliminary communication on this work has been published: Kurek-Tyrlik, A.; Michalak, K.; Urbanczyk-Lipkowska, Z.; Wicha, J. Tetrahedron Lett. 2004, 45, 7479-7482.
35. Przezdziecka, A.; Kurek-Tyrlik, A.; Wicha, J. Collect. Czech. Chem. Commun. 2002, 67, 1658-1668.
36. (a) Anciaux, A. J.; Hubert, A. J.; Noels, A. F.; Petiniot, N.; Teyssie, P. J. Org. Chem. 1980, 45, 695-702.
37. (b) Majchrzak, M. W.; Kotełko, A.; Lombert, J. B. Synthesis 1983, 469-470.
38. (a) Doyle, M. P.; McKervey, M. A. J. Chem. Soc. Chem. Commun. 1997, 983-989.
39. (b) Maas, G. Chem. Soc. Rev. 2004, 33, 183-190.
40. (c) Doyle, M. P. Chem. Rev. 1986, 86, 919-939.
41. (a) Volkenburgh, R. v.; Greenlee, K. W.; Derfer, J. M.; Boord, C. E. J. Am. Chem. Soc. 1949, 71, 3595-3597.
42. (b) House, H. O.; Blankley, C. J. J. Org. Chem. 1968, 33, 47-53.
43. (c) Srikrishna, A.; Ramasastry, S. S. V. Tetrahedron Lett. 2004, 45, 379-382.
44. For a review, see: von Angerer, S. In Carbocyclic Three-Membered Ring Compounds, 4th ed.; de Meijere, A., Ed.; Georg Thieme Verlag: Stuttgart, 1996; Vol. E17c, p 2045-2053.
45. Parikh, J. R.; Doering, W. v. E. J. Am. Chem. Soc. 1967, 89, 5505-5507.
46. Boar, R. B.; Joukhadar, L.; McGhie, J.; Misra, S. C.; Barrett, A. G. M.; Barton, D. H. R.; Prokopiou, P. A. J. Chem. Soc. Chem. Commun. 1978, 68-69.
47. Cregge, R. J.; Herrmann, J. L.; Lee, C. S.; Richman, J. E.; Schlessinger, R. H. Tetrahedron Lett. 1973, 2425-2428.
48. Wicha, J.; Bal, K. J. Chem. Soc., Perkin Trans. 1 1978, 1282-1288;
49. Wicha, J.; Bal, K. J. Chem. Soc. Chem. Commun. 1975, 968-969.
50. For representative references, see: (a) Partridge, J. J.; Shiuey, S. J.; Chadha, N. K.; Baggiolini, E. G.; Blount, J. F.; Uskokoviæ, M. R. J. Am. Chem. Soc. 1981, 103, 1253-1255.
51. (b) Hutchinson, J. H.; Money, T. J. Chem. Soc. Chem. Commun. 1986, 288-289.
52. (c) Stork, G.; Saccomano, N. A. Tetrahedron Lett. 1987, 28, 2087-2090.
53. (d) Ibuka, T.; Taga, T.; Shingu, T.; Saito, M.; Nishii, S.; Yamamoto, Y. J. Org. Chem. 1988, 53, 3947-3952.
54. For a recent work, see: Mulzer, J.; Steffen, U.; Martin, H. J.; Zorn, L. Eur. J. Org. Chem. 2005, 1028-1043.
55. Fleming, I.; Lewis, J. J. J. Chem. Soc. Chem. Commun. 1985, 149-151.
56. (a) McGarvey, G. J.; Williams, J. M. J. Am. Chem. Soc. 1985, 107, 1435-1437.
57. (b) Paddon-Row, M. N.; Rondan, N. G.; Houk, K. N. J. Am. Chem. Soc. 1982, 104, 7162-7166.
58. (c) Schmid, G.; Fukayama, T.; Akasaka, K.; Kishi, Y. J. Am. Chem. Soc. 1979, 101, 259-260.
59. Partridge, J. J.; Faber, S.; Uskoković, M. Helv. Chim. Acta 1974, 57, 764-770.
60. In the present work, the orientation of the side chain is indicated as 17α (3β, 25-dihydroxy-17α-cholest-5-ene, 25-hydroxy-17α- cholesterol), in line with the IUPAC Nomenclature of Steroids, recommendations for derivatives with two alkyl substituents at C-17 (3S-2.7 and 3S-2.8). It should be noted that the generic name 5α,17α-cholestane comprises a discrepancy since the first numeral and letter (5α) relates to the hydrogen atom whereas the second (17α) to the carbon substituent.
61. Uskoković, M. R.; Barwid, T. A.; Jacobelli, J. A.; Baggiolini, E. In Chem. Abstr. 1977, 86, 16846; U.S. Patent 3,993,675, 1976.
62. (a) Havinga, E.; Kock, R. J. d.; Rappoldt, M. P. Tetrahedron 1960, 11, 276-284.
63. (b) Dauben, W. G.; Phillips, R. B. J. Am. Chem. Soc. 1982, 104, 5780-5781.
64. (c) Okabe, M.; Sun, R.-C.; Scalone, M.; Jibilian, C. H.; Hutchings, S. D. J. Org. Chem. 1995, 60, 767-771.
65. For selective capture of the previtamin derivative, see: Doi, T.; Yoshida, M.; Hijikuro, I.; Takahashi, T. Tetrahedron Lett. 2004, 45, 5727-5729.
66. (a) Peterson, P. E.; Breedlove Leffew, R. L.; Jensen, B. L. J. Org. Chem. 1986, 51, 1948-1954.
67. (b) Pappas, J. J.; Keaveney, W. P.; Gancher, E.; Berger, M. Tetrahedron Lett. 1966, 4273-4276.
68. Baggiolini, E. G.; Iacobelli, J. A.; Hennessy, B. M.; Uskoković, M. R. J. Am. Chem. Soc. 1982, 104, 2945-2948.
69. Daniewski, A. R.; Garofalo, L. N.; Kabat, M. M. Synth. Commun. 2002, 32, 3031-3039 and references quoted therein.